CollPlant Biotechnologies Ltd. (CLGN)

NASDAQ: CLGN · Real-Time Price · USD

0.3433

-0.0293 (-7.86%)

At close: Sep 2, 2026, 4:00 PM EDT

0.3200

-0.0233 (-6.79%)

After-hours: Sep 2, 2026, 7:59 PM EDT

CollPlant Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.26	5.59	11.91	26.67	29.65	13.15
Short-Term Investments	-	-	-	-	-	30.15
Cash & Short-Term Investments	4.26	5.59	11.91	26.67	29.65	43.3
Cash Growth	-60.30%	-53.05%	-55.35%	-10.05%	-31.52%	1199.10%
Accounts Receivable	0.01	0	0.15	-	0.01	0.27
Other Receivables	0.23	0.22	0.43	0.39	0.54	0.42
Receivables	0.23	0.22	0.58	0.39	0.55	0.69
Inventory	0.68	0.57	0.44	0.71	1.43	1.08
Other Current Assets	0.37	0.36	0.25	0.24	0.02	0.01
Total Current Assets	5.54	6.75	13.18	28.02	31.66	45.09
Property, Plant & Equipment	3.51	3.89	5.28	5.86	5.68	5.68
Other Intangible Assets	0.06	0.07	0.13	0.19	0.25	0.24
Other Long-Term Assets	0.08	0.08	0.12	0.06	0.19	0.21
Total Assets	9.18	10.79	18.71	34.13	37.77	51.22

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.64	0.61	0.87	0.98	1.13	1.03
Accrued Expenses	1.01	1.25	1.29	1.65	1.44	1.43
Current Portion of Leases	0.79	0.81	0.81	0.62	0.53	0.52
Current Unearned Revenue	-	-	-	-	-	0.03
Total Current Liabilities	2.44	2.67	2.97	3.25	3.11	3.01
Long-Term Leases	1.86	2.03	2.28	2.54	2.38	3.09
Total Liabilities	4.3	4.7	5.25	5.79	5.49	6.1

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	6.27	5.49	4.98	4.98	4.87	4.66
Additional Paid-In Capital	127.53	126.4	122.8	121.07	118.1	114.22
Retained Earnings	-127.94	-124.84	-113.35	-96.74	-89.72	-72.8
Comprehensive Income & Other	-0.97	-0.97	-0.97	-0.97	-0.97	-0.97
Shareholders' Equity	4.89	6.08	13.47	28.34	32.28	45.12
Total Liabilities & Equity	9.18	10.79	18.71	34.13	37.77	51.22

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.65	2.85	3.08	3.16	2.91	3.61
Net Cash (Debt)	1.61	2.75	8.83	23.52	26.74	39.69
Net Cash Growth	-79.56%	-68.91%	-62.46%	-12.07%	-32.63%	-
Net Cash Per Share	0.13	0.22	0.77	2.06	2.42	3.32
Filing Date Shares Outstanding	14.42	14.42	11.45	11.45	10.77	10.77
Total Common Shares Outstanding	14.42	12.8	11.45	11.45	10.77	10.77
Working Capital	3.1	4.08	10.21	24.77	28.55	42.07
Book Value Per Share	0.34	0.47	1.18	2.47	3.00	4.19
Tangible Book Value	4.83	6.01	13.33	28.15	32.04	44.88
Tangible Book Value Per Share	0.33	0.47	1.16	2.46	2.97	4.17
Machinery	-	5.68	5.66	5.33	4.7	4.11
Leasehold Improvements	-	3.66	3.65	3.5	3.31	2.63

SEC Filings: 10-K · 10-Q